Shortcut: IPA-210-PostCOV
Duration: Ongoing
Aim
Identification and application of an appropriate biomarker panel to characterize the heterogeneous post-COVID syndrome (PCS). The aim is to achieve a specific characterization of typical post-COVID subgroups, facilitating the distinction from COVID-19-independent diseases and to initiate specific therapeutic measures in the context of tertiary prevention.
Study design
Examination of a collective with a confirmed COVID-19 diagnosis or a recognized occupational disease BK 3101 according to COVID-19 “Infectious diseases, if the insured person was employed in healthcare, social welfare, or in a laboratory, or was exposed to a similar level of infection risk due to another occupational activities.”
